SCHEMBL8601356

SCHEMBL8601356

Fc1ccc(-c2[nH][c]nc2-c2ccncc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 17/20 0.55
MAPK13 O15264 12/20 0.55
MAPK12 P53778 12/20 0.55
MAPK11 Q15759 12/20 0.55
MAPK9 P45984 3/20 0.55
RAF1 P04049 2/20 0.55
GCGR P47871 10/20 0.54
PRKD3 O94806 2/20 0.54
MAP4K4 O95819 2/20 0.54
FRK P42685 2/20 0.54
CSNK1A1 P48729 2/20 0.54
CSNK1D P48730 2/20 0.54
GSK3B P49841 2/20 0.54
PTK6 Q13882 2/20 0.54
CLK4 Q9HAZ1 2/20 0.54
PRKD2 Q9BZL6 1/20 0.54
ALOX5 P09917 3/20 0.49
BRAF P15056 2/20 0.49
MAPK10 P53779 2/20 0.48
KDM4E B2RXH2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4045129 0.81 GPR55 (0.43) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL8605486 0.76 MAPK13 (0.46) MAPK14MAPK13MAPK12MAPK11MAPK9
SCHEMBL5258469 0.73 MAPK14 (0.69) MAPK14MAPK13MAPK12MAPK11MAPK9
SCHEMBL14519418 0.73 MAPK14 (0.69) MAPK14MAPK13MAPK12MAPK11MAPK9
SCHEMBL699188 0.72 KDM4E (0.45) MAPK14MAPK13MAPK12MAPK11MAPK9
SCHEMBL8606320 0.72 RAF1 (0.49) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL25220966 0.71 MAPK14 (0.57) MAPK14MAPK13MAPK12MAPK11MAPK9
SCHEMBL6423292 0.71 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11MAPK9
SCHEMBL4434902 0.71 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11MAPK9
SCHEMBL6626583 0.71 MAPK14 (0.57) MAPK14MAPK13MAPK12MAPK11MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5717100-A Substituted imidazoles having anti-cancer and cytokine inhibitory activity MERCK & CO., INC. (US) 1998-02-10 US disclosed